1. Home
  2. GKOS vs KRG Comparison

GKOS vs KRG Comparison

Compare GKOS & KRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • KRG
  • Stock Information
  • Founded
  • GKOS 1998
  • KRG 1971
  • Country
  • GKOS United States
  • KRG United States
  • Employees
  • GKOS N/A
  • KRG N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • KRG Real Estate Investment Trusts
  • Sector
  • GKOS Health Care
  • KRG Real Estate
  • Exchange
  • GKOS Nasdaq
  • KRG Nasdaq
  • Market Cap
  • GKOS 5.4B
  • KRG 5.0B
  • IPO Year
  • GKOS 2015
  • KRG 2004
  • Fundamental
  • Price
  • GKOS $87.64
  • KRG $22.35
  • Analyst Decision
  • GKOS Strong Buy
  • KRG Buy
  • Analyst Count
  • GKOS 13
  • KRG 10
  • Target Price
  • GKOS $120.38
  • KRG $26.20
  • AVG Volume (30 Days)
  • GKOS 718.5K
  • KRG 1.9M
  • Earning Date
  • GKOS 10-29-2025
  • KRG 10-29-2025
  • Dividend Yield
  • GKOS N/A
  • KRG 4.84%
  • EPS Growth
  • GKOS N/A
  • KRG N/A
  • EPS
  • GKOS N/A
  • KRG 0.79
  • Revenue
  • GKOS $432,953,000.00
  • KRG $857,126,000.00
  • Revenue This Year
  • GKOS $28.90
  • KRG $2.97
  • Revenue Next Year
  • GKOS $25.57
  • KRG $1.74
  • P/E Ratio
  • GKOS N/A
  • KRG $28.41
  • Revenue Growth
  • GKOS 26.70
  • KRG 3.60
  • 52 Week Low
  • GKOS $77.10
  • KRG $18.52
  • 52 Week High
  • GKOS $163.71
  • KRG $28.24
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 53.74
  • KRG 53.64
  • Support Level
  • GKOS $82.19
  • KRG $21.75
  • Resistance Level
  • GKOS $86.74
  • KRG $22.37
  • Average True Range (ATR)
  • GKOS 3.27
  • KRG 0.44
  • MACD
  • GKOS 0.56
  • KRG 0.02
  • Stochastic Oscillator
  • GKOS 82.87
  • KRG 87.78

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About KRG Kite Realty Group Trust

Kite Realty Group Trust specializes in owning, operating, acquiring, developing, and redeveloping high-quality open-air shopping centers and mixed-use assets. The company generates the majority of its revenue from contractual rents and reimbursement payments received from tenants.

Share on Social Networks: